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We have previously described a guinea-pig model where pigmented nevi similar to human nevi can be produced
by application of low-dose topical 7,12-dimethylbenzanthracene (DMBA) followed by solar-simulated light. Five
groups of guinea-pigs were used to test the effect of various spectral bands of solar-simulated light on low-dose
DMBA-induced melanocytic nevi. Animals were irradiated with either UVB to near UVA2 (290–325 nm), UVA, visible
light, full solar spectrum or no irradiation three times per wk for 12 mo to determine the broad-band effect of
nevi-inducing irradiation. There was a signiﬁcant increase in nevi/animal in the UVB-treated group (mean 1.53)
compared with all groups (versus UVA 0.3, po0.001; versus visible light 0.24, po0.001; versus full spectrum
(UVBþUVAþ visible) 0.68, p¼ 0.02; versus control (nil irradiation) 0.37, p¼ 0.01). No differences in skin thickness
were found between any group (p¼ 0.11). In conclusion, we present a report of the active waveband of melanocytic
nevi induction; where UVB to near UVA2 is the likely responsible waveband. Furthermore, because there was a
signiﬁcant decrease in nevi/animal receiving the full solar spectrum compared with the UVB group, it is possible
that broad-band UVA and or visible light may be inhibitory wavebands for nevi induction.
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Cutaneous melanoma continues to increase in incidence in
most continents of the world (Parkin et al, 1999). Strong
epidemiological evidence confirms the role of sun exposure
as the major cause of melanoma in humans (Armstrong and
Kricker, 2001). In addition, strong epidemiological evidence
supports the finding that the frequency of melanocytic nevi
(‘‘moles’’) is a good indicator of future development of
melanoma and a short-term marker of adverse reactions to
melanoma-inducing sun exposure in humans (Elwood and
Koh, 1994; Slade et al, 1995; Berwick and Halpern, 1997).
The latter is based on the associated increased frequency
of nevi with increasing sun exposure (Elwood and Koh,
1994; Kelly et al, 1994; Dwyer et al, 1995; Luther et al, 1996;
Berwick and Halpern, 1997; Dulon et al, 2002; Wiecker et al,
2003), with patterns of sun exposure inducing nevi similar to
that inducing melanoma (Gallagher et al, 1990; Wiecker
et al, 2003). Nevi are precursor lesions for melanoma, with
somewhere between 18 and 83% of melanomas having a
histologically contiguous nevus present (Friedman et al,
1988). Finally, gender differences in nevus density correlate
with site-specific melanoma incidence (Maclennan et al,
2003).
A fundamental question yet to be answered is defining
the action spectrum of melanoma and nevi induction. This
cannot be assessed in humans, but rather depends on
appropriate animal models. As noted previously (Menzies
et al, 1998), however, the majority of small animal models
of melanoma suffer from fundamental differences from
the human disease, making action spectrum experiments
difficult to extrapolate to primary human melanoma. These
differences include lack of solar-simulated light or UVR in
induction protocols (Millikan et al, 1985; Epstein, 1992;
Chen et al, 1996; Shapiro et al, 1996; Chin et al, 1997;
Kligman and Elenitsas, 2001; Krimpenfort et al, 2001) or,
when found, animals having a strong photoreactivation
system (Ley et al, 1989; Setlow et al, 1989; Robinson
et al, 2000), whereby DNA photolyase repairs UVR-induced
cyclobutane pyrimidine dimers by using the near UV-visible
component of sunlight (Sancar, 1994). This strong photo-
reactivation system is not found in humans (Kato et al,
1994). In addition, the majority of melanomas or nevi in
animal models arise from dermal melanocytes (Epstein et al,
1967; Husain et al, 1991; Takahashi et al, 1992; Klein-Szanto
et al, 1994; Shapiro et al, 1996; Chin et al, 1997; Kelsall and
Mintz, 1998; Zhu et al, 1998; Broom et al, 1999; Strickland
et al, 2000; Kligman and Elenitsas, 2001; Krimpenfort et al,
2001) rather than the epidermal derivation seen in humans.
Because of the limited penetration of UVR into the dermis of
Abbreviations: DMBA, 7,12-dimethylbenzanthracene; MED, mini-
mal skin erythema dose; UVR, UV radiation
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the skin (Parrish, 1983), the role of sunlight in the induction
of dermal-derived melanomas or melanocytic nevi cannot
be extrapolated to its role in human epidermally derived
melanoma and nevi. In one small laboratory animal model
of epidermally derived melanoma, these tumors have a
different natural history to the human disease (Hook et al,
1982).
There are currently only three small laboratory animal
models that satisfy the optimal criteria for a model for
human melanoma or nevi, that is, tumors are augmented by
solar-simulated light or UVR, have the same natural history
as human lesions and are histologically similar with a
distinct epidermal derivation, and are produced in an animal
lacking strong photoreactivation. First is a human skin
xenograft model using a low dose of 7,12-dimethylbenzan-
thracene (DMBA) followed by UVB to induce epidermally
derived melanocytic hyperplasia and melanoma (Atillasoy
et al, 1998; Sauter et al, 1998), or UVB alone on basic
fibroblast growth factor (bFGF)-transfected human skin to
induce atypical lentiginous hyperplasia (Berking et al, 2001).
Second is low-dose UVB exposed neonatal albino hepato-
cyte growth factor/scatter factor (HGF/SF)-transgenic mice
inducing melanoma (Noonan et al, 2001; Recio et al, 2002).
Finally, there exists our previously reported model of low-
dose DMBA followed by solar-simulated light in Hartley
albino guinea-pigs that induces melanocytic nevi histologi-
cally identical to human nevi (Menzies et al, 1998). In the
first two models, an action spectrum dissecting the relative
roles of each major component of sunlight in the formation
of the melanocytic lesions has not yet been reported.
As previously described, low-dose topical DMBA applied
to Hartley albino guinea-pigs followed by 12 mo of solar-
simulated light augments the induction of epidermally
derived pigmented melanocytic nevi (Menzies et al, 1998).
These nevi have the same clinical and histological appear-
ance of human nevi, in which junctional, compound, and
dermal nevi are found. S100 and HMB-45 staining is also
consistent with patterns seen in human nevi. Here, we
report a full broad-band analysis of UVB, UVA, and visible
light for the induction of melanocytic nevi in the guinea-pig
model.
Results
UVB augments the formation of nevi Five groups of
animals were used to determine the broad-band effect on
nevi induction (Table I).
Following a short treatment of topical application of low-
dose DMBA as previously described (Menzies et al, 1998),
animals were irradiated for 12 mo with either full solar
spectral light, UVB, UVA, visible light, or no irradiation to
determine the broad-band action spectrum of nevi-inducing
irradiation. There was a significant increase in nevi/animal
in the UVB-treated group (mean 1.53) compared with all
groups (versus UVA 0.3, po0.001; versus visible light 0.24,
po0.001; versus full spectrum (UVBþUVAþ visible) 0.68
p¼0.02; versus control (nil irradiation) 0.37, p¼ 0.01). No
significant difference was found between the control group
and other groups except UVB (Fig 1).
No difference in skin thickness between groups In order
to account for differences in nevi induction due to inter-
group variability in skin thickness, the mean interfollicular
viable epidermal thickness was determined in 10 animals
per group (see Materials and Methods). But there was no
significant difference between any group (control 30 mm (SD
5.3 mm), UVA 22 (4.5), UVB 25 (3.4), visible 28 (7.9), full
spectrum 24 (3.0); p¼ 0.11, one-way ANOVA).
Characteristics of induced nevi As described previously
(Menzies et al, 1998), the pigmented nevi formed in our
Table I. Nevi-inducing treatment regimens
Groupa Irradiation exposureb
1 UVB
2 UVA
3 Visible
4 UVBþUVAþ visible
5 Nil irradiation
aFemale animals, 2 mo of age, were randomly allocated into the above
groups (20 animals per group). Throughout the experiment, all animals
were shaved on the dorsum with clippers and excess hair was removed
with the depilatory cream Nair twice per week (Tuesday and Friday).
Commencing at week 0, each group received 0.6 mL of 0.1% DMBA
(Sigma Chemical Co., St Louis, Missouri) in acetone (wt/vol) two times
per wk (Monday and Thursday) applied to an area of approximately 10
cm  10cm mid-dorsal skin for 5 wk as previously described (Menzies
et al, 1998).
bAt week 11, each group received a variable regimen of irradiation
exposure three times per wk (Monday, Wednesday, and Friday) for a total
of 12 mo exposure according to our standard protocol (Menzies et al,
1998) (see Materials and Methods).
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Figure1
UVB augments the formation of nevi. Each treatment group is
defined in Table I. Nevi were scored when X2 mm diameter. Nevi
multiplicity (nevi/animal) was analyzed after 12 mo irradiation (week 53).
There was a significant increase in nevi/animal in the UVB-treated
group (mean 1.53) compared with all groups (versus UVA 0.3, po0.001;
versus visible light 0.24, po0.001; versus full spectrum (UVBþ
UVAþ visible) 0.68 p¼ 0.02; versus control (nil irradiation) 0.37,
p¼ 0.01). No significant difference was found between the control
group and other groups, except UVB (see statistical analysis in
Materials and Methods).
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guinea-pig model are clinically and histologically very
similar to those seen in humans. This was confirmed again
in these experiments. Table II shows the frequency of nevi
found on examination. All of the three major histological
patterns of human melanocytic nevi were found. Junctional
nevi had nests of round to oval melanocytes at the
dermoepidermal junction. Compound nevi showed nests
at the dermoepidermal junction in addition to nevus cells in
the dermis, and dermal nevi showed nevus cells exclusively
in the dermis. Blue nevi were composed of slightly
elongated, spindled pigmented melanocytes. In some nevi,
there were features of both ordinary compound nevus and
blue nevus, with melanocytic nests at the dermoepidermal
junction and in the dermis. The nests showed a mixture of
round to oval melanocytes that lacked or had little melanin,
and spindled pigmented melanocytes. Figure 2 shows
features of the main histological categories. Interestingly,
there was a significant increase in nevi with an epidermal
component in those animals receiving full solar spectrum
light (82%) compared with all other groups (14–43%);
p¼0.016. The diameter of nevi with an epidermal compo-
nent was 2-fold greater than those with a pure dermal
component; po0.001. These observations, however, oc-
curred at one time point only, and thus do not provide
details of earlier histological features of the nevi (Menzies
et al, 1998).
Discussion
As stated in the introduction, nevi have been shown in
humans to be good indicators of future melanoma devel-
opment and short-term markers of the adverse reactions to
melanoma-inducing sun exposure. Thus, this animal model
can be considered as a surrogate model for sunlight-
induced primary melanoma in humans. Our results show
that the wavelengths responsible for nevi induction are likely
to lie within the 290–325 nm range (UVB to early UVA2).
Although some low levels of contaminating UVA occur with
the UVB source, the irradiance beyond 325 nm is relatively
low compared with the UVA source. Surprisingly, the UVB-
exposed group had a significantly increased nevi multiplicity
compared with the group exposed to the full solar-
spectrum, which indicates that the full spectrum sunlight
is less effective than its UVB component alone in producing
nevi. This may indicate that UVA and or visible light had
some protective effect from nevi induction. Since this is a
study that utilizes full solar spectrum light into the visible
component, no supportive comparative studies using
other animal models exist. But because of the probable
complex interactions taking place with different wave-
lengths of light, caution in over-interpreting the data in
terms of the protective roles of other wavebands needs to
be highlighted.
The failure of the full spectrum to induce a significantly
increased nevi induction compared with our previous report
(Menzies et al, 1998) may also support the observation
that UVB induces nevi and wavelengths beyond may have
a protective role. In the original solar-simulator used
to describe the model, there was a relatively increased
component of UVB (particularly within the early wave-
lengths) and a significantly decreased visible light compo-
nent compared with the more accurate solar simulator used
in these studies. It should also be noted that there was an
obvious separation in the incidence of nevi between the
group receiving full spectrum irradiation and the control
group, which failed to reach statistical significance. This
may simply reflect a sample size deficiency.
The observation that nevi have a significantly increased
epidermal component when animals were irradiated with
the full solar-simulated spectrum compared with UVB, UVA,
visible, and non-irradiated animals may indicate that
biologically important interactions occur when combining
these broad wavebands. But such static observation of nevi
at one time point does not exclude the likely epidermal
origin of all the nevi, as previously described (Menzies et al,
1998).
In the authors’ opinion, the use of topical DMBA to
induce a background nevus-prone animal does not deleter-
iously affect the significance of this model for the human
disease. This is because sunlight is not the main etiological
agent for nevi induction in humans. Rather, a strong genetic
Table II. The histological classiﬁcation of nevi biopsied
Full spectrum UVB UVA Visible Control
Lentigo 0 (0)a 1 (3) 0 (0) 0 (0) 0 (0)
Junctional nevi 1 (9) 0 (0) 0 (0) 0 (0) 0 (0)
Compound nevi 3 (27) 7 (23) 1 (14) 1 (14) 0 (0)
Compound nevi with blue-like elements 5 (45) 4 (13) 0 (0) 2 (29) 2 (18)
Dermal nevi 0 (0) 0 (0) 1 (14) 0 (0) 0 (0)
Blue nevi 2 (18) 19 (61) 5 (71) 1 (14) 7 (64)
Dermal nevi with blue-like elements 0 (0) 0 (0) 0 (0) 3 (43) 2 (18)
Nevi with epidermal component 9 (82)b 12 (39) 1 (14) 3 (43) 2 (18)
Nevi with pure dermal component 2 (18) 19 (61) 6 (85) 4 (57) 9 (82)
aAbsolute numbers with percentages in parentheses.
bThere is a significant increase in the proportion of nevi with an epidermal component in animals receiving the full solar spectrum compared with other
groups (p¼ 0.016 Fisher’s exact test).
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pre-disposition to nevi induction is reflected by the strong
correlation of nevus counts in monozygotic compared with
dizygotic twins (Easton et al, 1991; Wachsmuth et al, 2001).
Nevertheless, the interaction of sunlight exposure in such
nevus-prone individuals increases nevus production (El-
wood and Koh, 1994; Kelly et al, 1994; Dwyer et al, 1995;
Luther et al, 1996; Berwick and Halpern, 1997; Wachsmuth
et al, 2001; Dulon et al, 2002; Wiecker et al, 2003), as in our
guinea-pig model. No interaction occurs with sunlight and
DMBA itself in this model, since DMBA application is
ceased 5 wk prior to commencing irradiation. Hence, DMBA
is used to induce a genetic susceptibility to nevi induction
in the guinea-pigs. Since the genetic loci responsible for
inheriting a pre-disposition to nevi in humans remain
unknown, no investigations can be carried out to correlate
the genetic events in our model with the human condition.
Clearly, the most ideal animal model would contain the
analogous genetic loci found in humans with multiple nevi.
Finally, although melanomas are not seen using the protocol
described in our model, this is consistent with the rare event
(1 in 3000–10,000 life time risk) of an individual nevus
transforming into melanoma in humans (Tsao et al, 2003).
Indeed, if melanomas were commonly found in this model, it
would not be consistent with observations of the human
condition. Nevertheless, with other protocols using higher
doses of DMBA application, epidermally derived invasive
melanoma as seen in humans can be formed in this guinea-
pig model (Pawlowski et al, 1980; Menzies et al, 1998).
To our knowledge, only three other animal model
systems have directly compared different wavebands for
their capacity to induce melanocytic lesions. In the adult
opposum Monodelphis domestica, chronic exposure to
2.5 W per m2 of UVBþUVA2 (280–340 nm, peak 315 nm)
compared with 7.0 W per m2 of UVA1 (340–400 nm, peak
370 nm) showed no significant difference in the induction of
melanocytic hyperplasia, the putative precursor of melano-
ma in this model (Ley, 1997). In an indirect comparison
using a combination of studies, exposing neonatal oppo-
sums with 1.6 kJ per m2 of UVBþUVA2 compared with
23 kJ per m2 narrow band 365 nm UVA1 or broad-band UVA
320–400 nm and some visible light showed a grossly
increased induction of melanoctyic hyperplasia with the
UVB treatment groups (Robinson et al, 2000). In the
Xiphophorus fish model, melanoma induced in animals
irradiated with UVBþUVA2 (290–340 nm) or 304–340 nm
could be reversed by exposure to visible light after UVR
irradiation (Setlow et al, 1989). Fish irradiated with narrow
wavebands of 302, 313, 365, 405, and 436 nm were used to
determine the action spectrum. Extrapolating with the
sunlight spectra showed that 90–95% of melanoma induc-
tion was attributed to wavelengths greater than 320 nm
(Setlow et al, 1993). The usefulness of both these animal
Figure 2
Characteristics of induced nevi. (A) Compound nevus from an animal receiving full spectrum irradiation. (B) Histology of the compound nevus.
Here, both the junctional and dermal components are composed of small nevus cells (H&E stain). (C) Compound nevus with blue component from
an animal receiving UVB irradiation. (D) Histology of compound nevus with blue component. The dermal component is composed of spindled
pigmented cells (H&E stain).
UVB INDUCES NEVI IN A GUINEA-PIG MODEL 357123 : 2 AUGUST 2004
models, M. domestica and Xiphophorus, however, are
compromised by their strong photoreactivation system
and the non-epidermal origin of their melanocytic lesions.
Hairless mice exposed to topical DMBA followed by chronic
exposure to UVBþUVA2 (280–340 nm), UVA (320–400 nm),
or both showed no significant difference in melanoma
induction between the three groups (Husain et al, 1991). But
this model is again compromised by the non-epidermal
origin of the melanomas.
Epidemiological observations on human exposure to
sunlight or various components of light show complex
results with regard to melanoma or nevi risk. Although there
is overwhelming evidence on the role of sunlight in
melanoma and nevi risk, cumulative occupational exposure
to the sun as well as exposure in good tanners appear to be
protective for melanoma. Hence, the causal effects of
sunshine are difficult to dissect (Bataille et al, 2003). The
difficulty in measuring the type and quantity of exposure
and the confounders of sun protection application and true
skin phototype create complexities difficult to control with
standard epidemiological observations. The association of
sunbed exposure, a relatively high UVA source of light, and
melanoma is controversial, with some studies showing no
effect and others a weak risk (Bataille et al, 2003). In one
study, unlike for PUVA treatment, exposure to UVB
phototherapy in patients with psoriasis did not show any
increased risk for melanoma (Stern et al, 2001). All these
studies, however, suffer from the difficulty of dissecting the
role of the intervention exposure compared with routine sun
exposure. The control of such positive confounders is the
inherent advantage of animal models in dissecting wave-
band influences on tumor risk.
UVB and UVA are known to have distinctly different
biological effects on the skin (reviewed in de Gruijl et al,
2001; Wang et al, 2001). The predominant solar DNA
damage appears to be the pyrimidine dimer. These are
formed by UVB and UVA2 in the solar spectrum, and are
responsible for the majority of point mutations in CDKN2A,
one of the most prevalent genetic defects found in
melanoma. UVA has been shown to induce DNA damage
and mutations from photosensitized reactions via the
production of oxygen radical species. In cultured human
melanocytes, single strand breaks induced by UVA corre-
late with the level of melanin content. This suggests that
UVA interaction with these chromophores is responsible
for at least some mutagenic photosensitizing reactions. In
human fibroblasts, oxidative base damage extends even
into the near visible light (434 nm) (reviewed in de Gruijl
et al, 2001; Wang et al, 2001). But on the assumption that
melanocytic nevi require mutational events for their for-
mation, as suggested by the high frequency of mutations
found in the RAS/RAF/MAPK pathway (Pollock et al, 2003),
one would hypothesize that the most mutation-inducing
component of sunlight (UVB) would also be the most nevi
(and melanoma)-inducing component. This hypothesis is
supported by our study.
Materials and Methods
Animals Specific pathogen-free female outbred Hartley albino
guinea-pigs were purchased from Charles River Laboratories
(Wilmington, Massachusetts) and maintained under non-barrier
conditions in large pens with sawdust and hay bedding (10 animals
per pen) at 221C with 12-h light (fluorescent tubes that do no emit
any UVR) followed by 12-h dark. They were fed guinea-pig pellets
(high energy Glen Forest Stockriders, Perth, Australia) ad libitum
and supplemented with luserne. Vit C was added at 1 g per liter
drinking water three times per wk. All bedding, food and water
were autoclaved for 5–6 mo and then gradually decreased, without
any infectious adverse events. All procedures were cleared by the
local Animal Ethics Committee.
Nevi-inducing treatment regimens Five groups of guinea-pigs
were used to test the effect of various spectral bands of solar-
simulated light on low-dose DMBA-induced melanocytic nevi
(Table I).
Light irradiation system and regimen The F3S solar simulator is
unique in large area irradiation systems because of the high
irradiance of the visible light source with close solar simulation
(Supplemental online material, Fig S1). The full spectrum solar
simulator is composed of a multiple lamp array configured to
simulate the full spectrum of terrestrial sunlight at the equator at
mid-summer noon and variable throughout each major spectral
bandwidth. It comprises 6 Philips FL15SE UVB tubes filtered
through a 0.025 inch Kodacel 407 cellulose triacetate film, which
only slightly photodegrades after 30 h of use, eight Cosmolux VHO
CA 2-12-140W UVA tubes, eight Philips TL140/03 blue-visible
tubes, and 25 Tungsten Sylvania ELC 24V, 250W visible/IR lamps.
The UVB tubes were mounted within their own batten, which scans
across the entire exposure area at 5 s intervals. This ensured
uniformity of UVB irradiance over the entire exposure area. The
area of uniform irradiance under the lamps is 1200 mm  780 mm.
The spectral irradiance was originally measured and calibrated
(250–2400 nm) using a computer-controlled McPherson triple
grating-monochromater with a prism disperser. A calibrated
tungsten–halogen lamp was used as the reference source. For
this study, the solar simulator was also measured prior to and
at the completion of the study with a portable OL Series 754
UV–visible–NIR spectroradiometer (Optronics Laboratories, Inc.,
Orlando, Florida). The simulator was monitored before and after
every exposure using an International Light 1700 Research Radio-
meter (International Light, Inc., Newburyport, Massachusetts) com-
bined with two sensor attachments: an SED240 with an SC280 UVB-
1filter, and a W diffuser, and an SEE038 sensor, broad-band UVA
filter, and W diffuser. A series of NS filters spanning the 400–1000 nm
range in 100 nm steps was also used with the SEE038 sensor.
Each component of the full solar spectrum (UVB, UVA, and
visible light) can be controlled independently (Supplemental online
material, Fig S1). The UVB source has some early UVA2
component (290–325 nm) relative to the UVA source. Animals
were irradiated three times per wk for a total of 12-mo exposure as
described in Table I. In Group 4, animals were irradiated with the
full solar-simulated light (UVBþUVAþ visible) in escalating doses
to maintain minimal erythema. The dose range per exposure from
the beginning to the conclusion of the experiment was 3.9–7.2 J
per cm2 (290–800nm). The doses of UVB (Group 1), UVA (Group 2)
and visible light (Group 3) were determined and escalated by giving
the exact dose of each waveband that Group 4 received, for
example, the dose of UVB given to Group 1 equalled the dose of
UVB given to Group 4 at any particular time.
Histological examination of nevi and skin thickness Nevi were
excised and fixed in 10% phosphate-buffered formalin, embedded
in paraffin, and stained with H&E. For skin thickness determination,
a piece of skin was taken from the mid dorso-lateral position using
a 6 mm punch biopsy in 10 animals per group. The skin was
bisected and processed as above. The minimum interfollicular
viable epidermal thickness was measured for each skin piece
(usually 10 measurements per skin piece) and the mean was
calculated.
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Statistical analysis Nevi were scored when X2 mm in diameter.
Nevi multiplicity (number of nevi per animal) was analyzed after
12 mo irradiation (week 53). This pre-determined time period was
based upon previous observations with this guinea-pig model
(Menzies et al, 1998). With count data, an ANOVA (which assumes
normality and constant variance) is inappropriate. A better analysis
for this type of data is a general linear model based on a Poisson
distribution with a log-link (McCullagh et al, 1989). In this analysis,
the log of the mean count is modelled in terms of the design
features, in this case differences between UVB, UVA, visible light,
full spectrum, and the control. With Poisson data the standard
errors are misleading and are not shown. Nevertheless, this
variation is taken into account in the analysis.
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